文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

格雷夫斯病的全球研究格局和新兴趋势:文献计量分析。

Global research landscape and emerging trends in Graves' disease: A bibliometric analysis.

机构信息

Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Clinical Lab, Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China.

出版信息

Medicine (Baltimore). 2024 Jun 14;103(24):e37963. doi: 10.1097/MD.0000000000037963.


DOI:10.1097/MD.0000000000037963
PMID:38875401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11175884/
Abstract

BACKGROUND: Graves' disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves' disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves' disease through data mining and integrated analysis of the existing literature. METHODS: We retrieved relevant literature on Graves' disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix. RESULTS: We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the "2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis" and the "Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy." Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves' disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves' ophthalmopathy, thyroid nodules, and thyroid cancer. CONCLUSION: This is the first comprehensive bibliometric study to summarize progress and trends in Graves' disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.

摘要

背景:Graves 病是一种常见的甲状腺疾病,也是导致甲状腺功能亢进的主要原因。人们对这种疾病的流行病学、发病机制、诊断、治疗和预后已经有了深入的了解。然而,关于 Graves 病的文献计量分析还很缺乏。我们旨在通过对现有文献的挖掘和综合分析,全面总结 Graves 病的研究进展和重点。

方法:我们从 Web of Science 数据库中检索了 2003 年至 2023 年与 Graves 病相关的文献,使用 CiteSpace 和 R 包 Bibliometrix 进行文献计量分析。

结果:我们从 132 个国家中确定了 10901 篇文献,过去 5 年来,出版物的数量稳步上升。美国在出版物数量上处于领先地位,加利福尼亚大学系统是主要的贡献机构。发表文献最多的期刊是 Thyroid,被引用最多的期刊是 Journal of Clinical Endocrinology and Metabolism。这些出版物涉及 2305 位作者,其中最有影响力的是 Antonelli Alessandro 和 Smith Terry。被引用最多的文章是“2016 年美国甲状腺协会关于甲状腺功能亢进和其他原因引起的甲状腺毒症的诊断和管理指南”和“甲状腺协会/欧洲 Graves 眼病小组关于 Graves 眼病管理的指南”。对被引文献、关键词的突现分析及其聚类分析表明,Graves 病的研究主要集中在临床管理、促甲状腺激素受体、甲状腺激素、自身免疫和炎症、Graves 眼病、甲状腺结节和甲状腺癌等方面。

结论:这是第一项全面的文献计量学研究,总结了 Graves 病研究的进展和趋势。这些结果突出了当前的研究热点和有前途的方向,为其他学者提供了有价值的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/3509144adf28/medi-103-e37963-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/900bfdce3ea6/medi-103-e37963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/10ae00cd7cff/medi-103-e37963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/8e3cd82e6576/medi-103-e37963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/3baa8ea4ba30/medi-103-e37963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/e33135eceabd/medi-103-e37963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/1b531ed4e7ee/medi-103-e37963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/2d361bfe9b5a/medi-103-e37963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/6339ee4dac09/medi-103-e37963-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/d78d1df08c13/medi-103-e37963-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/b544c846bf3d/medi-103-e37963-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/3509144adf28/medi-103-e37963-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/900bfdce3ea6/medi-103-e37963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/10ae00cd7cff/medi-103-e37963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/8e3cd82e6576/medi-103-e37963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/3baa8ea4ba30/medi-103-e37963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/e33135eceabd/medi-103-e37963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/1b531ed4e7ee/medi-103-e37963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/2d361bfe9b5a/medi-103-e37963-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/6339ee4dac09/medi-103-e37963-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/d78d1df08c13/medi-103-e37963-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/b544c846bf3d/medi-103-e37963-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e0a/11175884/3509144adf28/medi-103-e37963-g011.jpg

相似文献

[1]
Global research landscape and emerging trends in Graves' disease: A bibliometric analysis.

Medicine (Baltimore). 2024-6-14

[2]
Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.

Arq Bras Oftalmol. 2022-2-14

[3]
Emerging Insights in Thyroid Eye Disease Research from 2010 to 2022: Trends, Hot Spots, and Research Situation.

Semin Ophthalmol. 2025-4-14

[4]
Evolution and global research trends of immunity in diabetic nephropathy: a bibliometric and visual analysis from 2004 to 2023.

Int Urol Nephrol. 2024-10

[5]
Global hotspots and trends in diabetic peripheral neuropathy research from 2011 to 2023.

Medicine (Baltimore). 2024-8-9

[6]
Global hotspots and trends in Acanthosis nigricans research: A bibliometric and visualized analysis.

Skin Res Technol. 2024-9

[7]
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.

Cochrane Database Syst Rev. 2015-11-25

[8]
Overview of Graves Ophthalmopathy Literature From 1999 to 2019: Bibliometric Analysis.

Interact J Med Res. 2021-9-28

[9]
Emerging research themes in maternal hypothyroidism: a bibliometric exploration.

Front Immunol. 2024

[10]
Global scientific trends on thyroid disease in early 21st century: a bibliometric and visualized analysis.

Front Endocrinol (Lausanne). 2023

本文引用的文献

[1]
Mapping the path towards novel treatment strategies: a bibliometric analysis of Hashimoto's thyroiditis research from 1990 to 2023.

Front Endocrinol (Lausanne). 2023

[2]
Hyperthyroidism: A Review.

JAMA. 2023-10-17

[3]
Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.

Front Endocrinol (Lausanne). 2023

[4]
Knowledge mapping and global trends in the field of low-intensity pulsed ultrasound and endocrine and metabolic diseases: a bibliometric and visual analysis from 2012 to 2022.

Front Endocrinol (Lausanne). 2023

[5]
Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases.

Front Endocrinol (Lausanne). 2023

[6]
Interleukin (IL)-23, IL-31, and IL-33 Play a Role in the Course of Autoimmune Endocrine Diseases.

Endocr Metab Immune Disord Drug Targets. 2024

[7]
TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease.

Int Immunopharmacol. 2023-11

[8]
A role of NR4A2 in Graves' disease: regulation of Th17/Treg.

Endocrine. 2024-2

[9]
Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA).

Diagnostics (Basel). 2023-8-19

[10]
Stability of TSH receptor antibody concentrations and comparability of its immunoassays.

Clin Chim Acta. 2023-8-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索